After the Colorado legislature rejected funds for a program that reduced teen pregnancies in Colorado by 40 percent over five years, the state’s chief medical officer said he’ll seek money for the program from private foundations.
Republicans in Colorado are coming up with a plethora of reasons to object to funding an IUD program that has dramatically reduced teen pregnancy. But their real concern appears to be that the program is too good at preventing unintended pregnancy.
Citing inaccurate science, a leading Colorado lawmaker is signaling he’ll oppose providing funds for a state program that, during a five-year privately-supported test phase, reduced teen pregnancies by 40 percent.
Because Depo-Provera is an important contraceptive choice and because in many parts of the world, it is the only long-acting, discreet option available to women, it is vital to take the issue of a link between HIV and hormonal contraception quite seriously while adding nuance to the discussion.
Intrauterine devices were popular until the ’70s, when one model caused infertility and even death in some women. Though the new generation of IUDs are safe and effective, it has been a slow climb back to their previous rates of acceptance.
Between the high-tech sex toys, transplanted uteri, lab-grown penises, and perils of hookup apps, 2014 sometimes sounded like a science fiction novel. But we can’t forget the news about IUDs and STIs that came out this year, either.
In an effort to reduce unintended pregnancy and improve birth outcomes, some states are working to make intrauterine devices easier for Medicaid patients to access.
In a debate Tuesday night, Colorado gubernatorial candidate Bob Beauprez said he’s opposed to using tax dollars for abortion. As a result, he said, he’d oppose using state funds for intrauterine devices (IUDs), which he believes cause abortions.
Intrauterine devices (IUDs) and implants are highly effective at preventing pregnancy and safe for women of all ages. Many think they are the ideal contraceptive method for adolescent girls. The American Academy of Pediatrics weighed in this week.
For women in countries and communities with limited contraceptive choices and high rates of HIV, particularly in sub-Saharan Africa, a shortage of funding for the ECHO (Evidence for Contraceptive Options and HIV Outcomes) trial is an unacceptable development.